Core Points - The company has approved the first grant of restricted stock under the 2025 Restricted Stock Incentive Plan, with a total of 11.5 million shares to be granted to 618 recipients at a price of 7.28 yuan per share, effective on October 30, 2025 [2][6][23] Summary by Sections Grant Details - The first grant date for the restricted stock is set for October 30, 2025 [2] - A total of 11.5 million shares will be granted [2] - The grant price is established at 7.28 yuan per share [6] Decision Process - The decision-making process involved multiple meetings, including the board meeting on September 29, 2025, where the incentive plan was reviewed and approved [3][4] - The internal list of incentive recipients was publicly disclosed from October 9 to October 18, 2025, with no objections received [3] - The plan was approved by the shareholders at the first extraordinary general meeting on October 29, 2025 [4][5] Compliance and Conditions - The board confirmed that both the company and the recipients meet the necessary conditions for granting the restricted stock, as outlined in the relevant regulations [5][6] - The incentive plan includes performance assessment criteria that must be met for the release of the restricted stock [7][9] Financial Impact - The estimated total cost of the restricted stock incentive plan is projected to be 81.995 million yuan, with specific amortization details provided [19][20] - The actual financial impact will be determined based on the final audit report [20] Legal Opinions - Legal counsel has confirmed that all necessary approvals and authorizations for the stock grant have been obtained, and the conditions for granting the stock have been satisfied [21]

Core Viewpoint - Hailir, a significant player in the domestic pesticide industry, focuses on the research and production of pesticide formulations, active ingredients, and intermediates, showcasing substantial investment value due to its full industry chain advantages [1] Group 1: Business Performance - In Q3 2025, Hailir reported revenue of 3.391 billion yuan, ranking 12th among 32 peers, with the industry leader, Adama Agricultural Solutions, generating 21.678 billion yuan [2] - The main business revenue composition includes pesticide revenue of 3.808 billion yuan (97.46%), fertilizer revenue of 66.8459 million yuan (1.71%), and agricultural services revenue of 27.6076 million yuan (0.71%) [2] - The net profit for the same period was 208 million yuan, placing Hailir 11th in the industry, with the top performer, Yangnong Chemical, achieving a net profit of 1.056 billion yuan [2] Group 2: Financial Ratios - Hailir's debt-to-asset ratio in Q3 2025 was 50.39%, higher than the previous year's 47.12% and above the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 24.22%, slightly up from 24.05% year-on-year and above the industry average of 21.70% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 14.70% to 13,000, while the average number of circulating A-shares held per shareholder increased by 17.23% to 26,200 [5] - Notable changes among the top ten circulating shareholders include new entries from two funds, with one holding 2.7215 million shares and another holding 1.5519 million shares [5] Group 4: Management Compensation - The chairman, Ge Jiacheng, received a salary of 1.8463 million yuan in 2024, an increase of 320,300 yuan from 2023 [4] Group 5: Market Outlook - Analysts predict a gradual improvement in Hailir's performance, with expected net profits for 2025-2027 of 396 million yuan, 503 million yuan, and 543 million yuan, respectively, despite downward adjustments in forecasts [6]

Group 1 - The pesticide sector has experienced significant adjustments, with Hailier hitting the daily limit down [1] - Other companies such as Changqing Co., Runfeng Co., Yangnong Chemical, Andermatt A, Sully Co., and Xianda Co. also saw declines [1]

证券代码：603639 证券简称：海利尔 公告编号：2025-058 海利尔药业集团股份有限公司 关于公司第五届董事会第十二次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 2025 年 10 月 31 日 海利尔药业集团股份有限公司(以下简称"公司")第五届董事会第十二次会 议于 2025 年 10 月 30 日以通讯表决的方式召开。会议通知于 2025 年 10 月 27 日以电子邮件的方式发出，会议应到董事 9 名，实到董事 8 名，葛尧伦先生因个 人原因未出席会议。本次会议的召集和召开符合《中华人民共和国公司法》和《海 利尔药业集团股份有限公司章程》的有关规定，合法有效。 二、董事会会议审议情况 1、审议通过《关于向 2025 年限制性股票激励计划激励对象首次授予限制 性股票的议案》 根据《上市公司股权激励管理办法》《海利尔药业集团股份有限公司 2025 年 限制性股票激励计划（草案）》的有关规定，以及公司 2025 年第一次临时股东会 的授权，本次激励计划规定的授予条件已经成就 ...

证券代码：603639 证券简称：海利尔 公告编号：2025-059 海利尔药业集团股份有限公司 关于向 2025 年限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《海利 尔药业集团股份有限公司 2025 年限制性股票激励计划（草案）》（以下简称"本 激励计划"、"激励计划"）的相关规定以及公司 2025 年第一次临时股东会授权， 海利尔药业集团股份有限公司（以下简称"公司"）董事会认为本次激励计划规定 的限制性股票的授予条件已经成就，公司于 2025 年 10 月 30 日召开的第五届董 事会第十二次会议审议通过《关于向 2025 年限制性股票激励计划激励对象首次 授予限制性股票的议案》，确定公司本次限制性股票的首次授予日为 2025 年 10 月 30 日。现将有关事项说明如下： 一、限制性股票的授予情况 （一）已履行的决策程序和信息披露情况 1、2025 年 9 月 29 日，公司召开第五 ...

海利尔药业集团股份有限公司董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划激励对象名单（授予 日）的核查意见 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和 国证券法》（以下简称《证券法》）、《上海证券交易所股票上市规则》《上市 公司股权激励管理办法》（以下简称《管理办法》）等法律法规、规范性文件以 及《海利尔药业集团股份有限公司章程》（以下简称《公司章程》）的规定，海 利尔药业集团股份有限公司（以下简称"公司"）董事会薪酬与考核委员会对公 司 2025 年限制性股票激励计划（以下简称《激励计划》）首次授予的授予条件 及激励对象名单（授予日）进行了核查，并发表核查意见如下： 1、公司不存在《管理办法》第七条规定的不得实施股权激励的情形： （1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无 法表示意见的审计报告； （3）上市后最近36个月内出现过未按法律法规、公司章程、公开承诺进行 利润分配的情形； （4） 法律法规规定不得实行股权激励的； （5） 中国证监会认定的其他情 ...

注：1、上表中部分合计数与各明细数相加之和在尾数上如有差异，系四舍五入所致。 2、公司全部在有效期内的股权激励计划所涉及的标的股票总数累计未超过公司股本总 额的10%；预留权益比例未超过本激励计划拟授予权益数量的20%。本次激励计划中任何一 名激励对象通过全部在有效期内的股权激励计划获授的本公司股票累计未超过公司股本总 额的1%。 3、本激励计划的激励对象不包括独立董事、单独或合计持有公司 5%以上股份的股东 及上市公司实际控制人的配偶、父母、子女。 海利尔药业集团股份有限公司 2025 年限制性股票激励计划激励对象名单（授予日） 海利尔药业集团股份有限公司（以下简称"公司"）2025 年限制性股票激励计 划（以下简称"本激励计划"）的激励对象名单（授予日）及拟授出权益分配情况： | 序号 | 姓名 | 岗位 | 获授的限制性 股票数量（万 | 占本激励计 划拟授出全 | 占本计划 公告时公 | | --- | --- | --- | --- | --- | --- | | | | | 股） | 部权益数量 | 司股本总 | | | | | | 的比例 | 额的比例 | | 1 | 徐洪涛 | 董事、总裁助理 ...

北京市金杜（青岛）律师事务所 关于海利尔药业集团股份有限公司 2025 年限制性股票激励计划首次授予事项的 法律意见书 致：海利尔药业集团股份有限公司 北京市金杜（青岛）律师事务所（以下简称金杜或本所）接受海利尔药业集 团股份有限公司（以下简称海利尔或公司）委托，作为其实施 2025 年限制性股 票激励计划（以下简称本激励计划、本次激励计划或本计划）的专项法律顾问， 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、中国证券监督管理委员会（以下简称中国证监 会）《上市公司股权激励管理办法》（以下简称《管理办法》）、《上海证券交 易所股票上市规则》（以下简称《上市规则》）、《上海证券交易所上市公司自 律监管指南第 2 号——业务办理》（以下简称《业务办理指南》）等法律、行政 法规、部门规章及规范性文件（以下简称法律法规）和《海利尔药业集团股份有 限公司章程》（以下简称《公司章程》）、《海利尔药业集团股份有限公司 2025 年限制性股票激励计划（草案）》（以下简称《激励计划（草案）》）的有关规 定，就公司本激励计划首次授予（以下简称本次授予）所涉及的相关事项，出 ...

Market Overview - The agricultural chemical sector experienced a decline of 0.75% on October 30, with Hai Li Er leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Dongfang Tieta (002545) with a closing price of 17.71, up 2.61% and a trading volume of 382,500 shares [1] - Yuntu Holdings (002539) closed at 10.64, up 2.41% with a trading volume of 384,900 shares [1] - Hualu Hengsheng (600426) closed at 25.75, up 1.90% with a trading volume of 191,200 shares [1] - Major decliners included: - Hai Li Er (603639) closed at 13.44, down 9.98% with a trading volume of 151,800 shares [2] - Changqing Co., Ltd. (002391) closed at 6.07, down 6.76% with a trading volume of 614,600 shares [2] - Yangnong Chemical (600486) closed at 64.81, down 4.85% with a trading volume of 88,300 shares [2] Capital Flow - The agricultural chemical sector saw a net outflow of 850 million yuan from institutional investors, while retail investors contributed a net inflow of 695 million yuan [2][3] - The main capital inflow and outflow for selected stocks included: - Dongfang Tieta (002545) had a net inflow of 77.12 million yuan from institutional investors [3] - Hualu Hengsheng (600426) experienced a net inflow of 50.55 million yuan from institutional investors [3] - Hai Li Er (603639) saw a significant net outflow of 20.7 million yuan from institutional investors [3]

Group 1 - Company Hailier (SH 603639) announced on October 29 that its 11th meeting of the 5th Board of Directors was held via communication voting on October 29, 2025 [1] - The meeting reviewed the proposal regarding the company's Q3 2025 report and other documents [1] Group 2 - As of the time of reporting, Hailier's market capitalization is 5.1 billion yuan [2]